ARTICLE
5 November 2020

Can AI Transform Precision Medicine?

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
Artificial Intelligence (AI) has changed our lives. Improvements in data mining, personal and automotive navigation, cybersecurity, personal entertainment and healthcare are several examples...
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Artificial Intelligence (AI) has changed our lives. Improvements in data mining, personal and automotive navigation, cybersecurity, personal entertainment and healthcare are several examples of the impact of AI.1 Recognizing that technological process can be measured by a review of the patent literature, the USPTO recently examined the patent literature from 1976 through 2018 to gauge the potential impact of AI on technology and innovation.2 It found a significant increase in patents using or covering AI. Patents containing AI appeared in about 42% of all technology subclasses in 2018 as compared to only 9% in 1976. The study also reported that the percentage of inventor-patentees active in AI started at 1% in 1976 and increased to 25% by 2018. Similar growth was reported for organizations patenting in AI.3

AI in Precision Medicine

Precision medicine recognizes that patient subpopulations can be identified who differ in their disease risk, prognosis and response to treatment due to differences in underlying biology and other characteristics.4 However, to develop personalized therapies, vast amounts of "data and insights on different individuals are required to create truly personalized medicine and care, and often these huge datasets cannot be collected or analyzed manually."5 Machine learning can assist with this analysis6 and indeed already has. High performance computers and AI algorithms have been shown to predict risk in "certain cancers and cardiovascular disease from available multidimensional clinical and biological data." 7. Using the results of pathological specimens, AI algorithms also have applied learning strategies to predict diagnosis and staging from pathological specimens received from a new patient.8

Promises and Challenges of AI

Advances in data collection and analysis can serve to advance precision medicine. As the amount of collected data increases, AI can manage and analyze this data for the benefit of patients.  

Foley & Lardner and the California Technology Council have produced a series of podcasts that explore data science, machine learning and artificial intelligence. While not limited to the advances that AI can and have brought to precision medicine, the series' experts touch on many issues relevant to precision medicine such as data integrity, cybersecurity, data bias, and patenting AI-inspired technologies.

The first episode begins with Ken DeJarnett, an expert in technology risk who recently retired from a long career at Deloitte. Mr. DeJarnett discusses improved decisions from mass quantities of data and discerning more impactful decision-making. A link to the podcast can be found here.

Footnotes

1. See content.techgig.com/5-ways-ai-has-transformed-our-lives/articleshow/76230907.cms.

2. Inventing AI: Tracing the diffusion of artificial intelligence with U.S. patents, Office of the Chief Economist, IP Data Highlights, Number 5, October 2020, page 2.

3. Id. at page 2 and 7-9.

4. Uddin, M. et al. (2019) Artificial intelligence for precision medicine in neurodevelopmental disorders, npj Digit. Med. 2, at page 2.

5. See Alan Payne, The role of AI in advancing personalized healthcare, available at www.techradar.com/news/the-role-of-ai-in-advancing-personalized-healthcare Sept 22 2020.

6. Id.

7. Uddin et al. (2019), at page 1.

8. Id. at page 4.

9. Id. at page 2.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More